PEAK6 Investments L.P. bought a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 8,878 shares of the company’s stock, valued at approximately $657,000.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Cornerstone Capital Management Holdings LLC. raised its stake in USANA Health Sciences by 83.9% during the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 60,700 shares of the company’s stock valued at $4,494,000 after purchasing an additional 27,700 shares during the period. Teachers Advisors LLC raised its stake in USANA Health Sciences by 1.2% during the 4th quarter. Teachers Advisors LLC now owns 211,824 shares of the company’s stock valued at $15,686,000 after purchasing an additional 2,506 shares during the period. Stone Ridge Asset Management LLC bought a new stake in USANA Health Sciences during the 4th quarter valued at approximately $265,000. Cornercap Investment Counsel Inc. raised its stake in USANA Health Sciences by 116.8% during the 4th quarter. Cornercap Investment Counsel Inc. now owns 24,990 shares of the company’s stock valued at $1,851,000 after purchasing an additional 13,465 shares during the period. Finally, Deutsche Bank AG raised its stake in USANA Health Sciences by 15.4% during the 4th quarter. Deutsche Bank AG now owns 142,912 shares of the company’s stock valued at $10,581,000 after purchasing an additional 19,091 shares during the period. 48.25% of the stock is currently owned by institutional investors.
Several analysts recently issued reports on the company. Pivotal Research lifted their target price on USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. TheStreet downgraded USANA Health Sciences from a “b+” rating to a “c+” rating in a research note on Tuesday, February 6th. Finally, Sidoti downgraded USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th.
Shares of USANA Health Sciences, Inc. (NYSE USNA) opened at $81.90 on Thursday. The stock has a market capitalization of $1,934.77, a P/E ratio of 20.01 and a beta of 0.94. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $82.40.
USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.11. The business had revenue of $273.11 million during the quarter, compared to analysts’ expectations of $258.67 million. USANA Health Sciences had a return on equity of 27.08% and a net margin of 5.97%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.87 EPS. equities analysts anticipate that USANA Health Sciences, Inc. will post 4.25 earnings per share for the current year.
In other USANA Health Sciences news, CFO G Doug Iiekking sold 2,423 shares of the firm’s stock in a transaction that occurred on Wednesday, March 7th. The stock was sold at an average price of $81.05, for a total transaction of $196,384.15. Following the completion of the transaction, the chief financial officer now owns 2,423 shares in the company, valued at approximately $196,384.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Myron W. Wentz sold 228,000 shares of the firm’s stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $81.10, for a total value of $18,490,800.00. The disclosure for this sale can be found here. Insiders have sold a total of 689,767 shares of company stock valued at $54,575,633 in the last 90 days. 53.20% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “PEAK6 Investments L.P. Takes Position in USANA Health Sciences, Inc. (USNA)” was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://ledgergazette.com/2018/03/15/peak6-investments-l-p-takes-position-in-usana-health-sciences-inc-usna.html.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.